BrightSpring Health Services, Inc.
For the period ended Mar 31, 2026. Filed May 1, 2026.
View on SEC.govAbout this filing
A company's report for each of its first three quarters. The financial statements are not audited. It shows how the business has moved since the last annual report, and what management says changed.
Mar 31, 2026 · Filed May 1, 2026
BTSG$72.49+4.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Condensed Consolidated Statements of Shareholders' Equity
(In thousands, except share data)
| Common Stock · Additional Paid-In Capital · (Accumulated Deficit) Retained Earnings · Accumulated Other Comprehensive Loss · NoncontrollingInterest · Total | |||||||
|---|---|---|---|---|---|---|---|
| Shares · Amount | |||||||
| Balances at December 31, 2025 | 192,124,125 | $1,921 | $1,954,482 | $(74,647) | $(6,691) | $74 | $1,875,139 |
| Net income (1) | — | — | — | 148,767 | — | 2 | 148,769 |
| Other comprehensive income, net of tax | — | — | — | — | 5,426 | — | 5,426 |
| Share-based compensation | — | — | 3,676 | — | — | — | 3,676 |
| Exercise of stock options | 1,377,708 | 14 | 12,078 | — | — | — | 12,092 |
| Issuance of common stock for settlement of RSUs | 1,316,385 | 13 | (13) | — | — | — | — |
| Tax effect of net share settlement of equity awards | (143,689) | (1) | (5,707) | — | — | — | (5,708) |
| Share repurchase | (1,464,807) | (15) | — | (59,985) | — | — | (60,000) |
| Other | — | — | — | — | — | (13) | (13) |
| Balances at March 31, 2026 | 193,209,722 | $1,932 | $1,964,516 | $14,135 | $(1,265) | $63 | $1,979,381 |
| Common Stock · Additional Paid-In Capital · Accumulated Deficit · Accumulated Other Comprehensive Income (Loss) · NoncontrollingInterest · Total | |||||||
|---|---|---|---|---|---|---|---|
| Shares · Amount | |||||||
| Balances at December 31, 2024 | 174,245,990 | $1,742 | $1,866,850 | $(222,155) | $1,418 | $— | $1,647,855 |
| Net income (loss) (1) | — | — | — | 29,542 | — | (125) | 29,417 |
| Other comprehensive loss, net of tax | — | — | — | — | (3,287) | — | (3,287) |
| Share-based compensation | — | — | 15,681 | — | — | — | 15,681 |
| Exercise of stock options | 36,253 | — | 345 | — | — | — | 345 |
| Issuance of common stock for settlement of RSUs | 1,052,536 | 11 | (11) | — | — | — | — |
| Tax effect of net share settlement of equity awards | (151,345) | (1) | (2,766) | — | — | — | (2,767) |
| Balances at March 31, 2025 | 175,183,434 | $1,752 | $1,880,099 | $(192,613) | $(1,869) | $(125) | $1,687,244 |
(1) Net income (loss) to the Company for the three months ended March 31, 2026 and 2025 excludes$(159) and$(407), respectively, allocable to the redeemable noncontrolling interests for our joint venture arrangements.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.